Lung cancer is the leading cause of cancer-related deaths worldwide. It exhibits, at the
mesoscopic scale, phenotypic characteristics that are generally indiscernible to the human …

Lung cancer accounts for the main proportion of malignancy-related deaths and most
patients are diagnosed at an advanced stage. Immunotherapy and targeted therapy have …

Radiogenomics, focusing on the relationship between genomics and imaging phenotypes,
has been widely applied to address tumour heterogeneity and predict immune …

Lung cancer is one of the malignancies with higher morbidity and mortality. Imaging plays
an essential role in each phase of lung cancer management, from detection to assessment …

Lung cancer is the second most common cancer and the leading cause of cancer-related
death worldwide. Molecular imaging using [18 F] fluorodeoxyglucose Positron Emission …

With the development of genome sequencing, the role of molecular targeted therapy in
cancer is becoming increasingly important. However, genetic testing remains expensive …

Based on the advantages of revealing the functional status and molecular expression of
tumor cells, positron emission tomography (PET) imaging has been performed in numerous …

Background Ferroptosis is a recently recognized type of programmed cell death that is
involved in the biological processes of various cancers. However, the mechanism of …

Purpose More and more small brain metastases (BMs) in asymptomatic patients can be
detected even prior to their primary lung cancer with the development of MRI. The aim of this …

Radiomics is an advanced image-processing framework, which extracts image features and
considers them as biomarkers towards personalized medicine. Applications include disease …